Page 28 - V Imaging News Today

A new algorithm has been developed that can reliably detect two cardiovascular conditions -- hypertrophic cardiomyopathy and cardiac amyloidosis -- that are often difficult to diagnose.

A new consensus document makes recommendations on how to evaluate and manage COVID-associated myocarditis and long COVID; it also gives advice on when exercise can be resumed after COVID-19 infection.

Those assigned to CT angiography vs invasive angiography fared at least as well for clinical outcomes but had far fewer procedure-related complications in the pan-European DISCHARGE trial.

The findings from a prominent US healthcare system are surprising given the availability of transcatheter options and should sound the alarm for change, experts suggest.

A new global registry shows differences in time to reperfusion and early response rate between various approaches used to remove clots, but neurological outcomes look similar with all strategies.

Low-value cardiovascular care providing little or no benefit is common, potentially harmful, and costly, and it will take key stakeholders to combat the problem, the American Heart Association says.

The expanded indication for the SGLT2 inhibitor empagliflozin (Jardiance) now includes heart failure with mid-range or preserved left-ventricular ejection fraction — essentially all heart failure.

The robotic-assisted device allows TCD ultrasound to be performed much more easily, which is hoped to increase the number of patients able to undergo this gold standard screening technique.

The thrombolytic tenecteplase may have a role in reestablishing blood flow in patients with large-vessel acute ischemic stroke up to 24 hours after stroke onset, a new trial from China suggests.

A large, multicenter cohort study supports phenotype-based screening of first-degree family members of patients with confirmed DCM without input, necessarily, from genetic testing.